N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine

C119H148N30O15 — CID 161365846

IUPACN,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine
SMILESCCOc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.CN(C)C(=O)c1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)C1CCC1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)C1CCOC1.c1cnc2c(OC3CCC(Nc4ccc(-c5nn[nH]n5)cn4)CC3)cc(N3CCOCC3)cc2n1
InChIInChI=1S/C25H31N7O3.C24H27N9O2.C24H30N6O3.C23H30N4O4.C23H30N4O3/c1-31(2)24(33)17-15-28-25(29-16-17)30-18-3-5-20(6-4-18)35-22-14-19(32-9-11-34-12-10-32)13-21-23(22)27-8-7-26-21;1-6-22(27-15-16(1)24-29-31-32-30-24)28-17-2-4-19(5-3-17)35-21-14-18(33-9-11-34-12-10-33)13-20-23(21)26-8-7-25-20;1-2-32-23-15-22(27-16-28-23)29-17-3-5-19(6-4-17)33-21-14-18(30-9-11-31-12-10-30)13-20-24(21)26-8-7-25-20;28-23(16-5-10-30-15-16)26-17-1-3-19(4-2-17)31-21-14-18(27-8-11-29-12-9-27)13-20-22(21)25-7-6-24-20;28-23(16-2-1-3-16)26-17-4-6-19(7-5-17)30-21-15-18(27-10-12-29-13-11-27)14-20-22(21)25-9-8-24-20/h7-8,13-16,18,20H,3-6,9-12H2,1-2H3,(H,28,29,30);1,6-8,13-15,17,19H,2-5,9-12H2,(H,27,28)(H,29,30,31,32);7-8,13-17,19H,2-6,9-12H2,1H3,(H,27,28,29);6-7,13-14,16-17,19H,1-5,8-12,15H2,(H,26,28);8-9,14-17,19H,1-7,10-13H2,(H,26,28)
InChIKeyVPULHWTZOOUAFI-UHFFFAOYSA-N
MW2238.69 g/mol
LogP14.44
Rot. Bonds29

About N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine

N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine (PubChem CID 161365846) has the molecular formula C119H148N30O15 and a molecular weight of 2238.69 g/mol. Its IUPAC name is N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine.

Molecular Properties

Compound NameN,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine
PubChem CID161365846
Molecular FormulaC119H148N30O15
Molecular Weight2238.69 g/mol
Exact Mass2237.17
IUPAC NameN,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine
SMILESCCOc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.CN(C)C(=O)c1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)C1CCC1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)C1CCOC1.c1cnc2c(OC3CCC(Nc4ccc(-c5nn[nH]n5)cn4)CC3)cc(N3CCOCC3)cc2n1
InChIInChI=1S/C25H31N7O3.C24H27N9O2.C24H30N6O3.C23H30N4O4.C23H30N4O3/c1-31(2)24(33)17-15-28-25(29-16-17)30-18-3-5-20(6-4-18)35-22-14-19(32-9-11-34-12-10-32)13-21-23(22)27-8-7-26-21;1-6-22(27-15-16(1)24-29-31-32-30-24)28-17-2-4-19(5-3-17)35-21-14-18(33-9-11-34-12-10-33)13-20-23(21)26-8-7-25-20;1-2-32-23-15-22(27-16-28-23)29-17-3-5-19(6-4-17)33-21-14-18(30-9-11-31-12-10-30)13-20-24(21)26-8-7-25-20;28-23(16-5-10-30-15-16)26-17-1-3-19(4-2-17)31-21-14-18(27-8-11-29-12-9-27)13-20-22(21)25-7-6-24-20;28-23(16-2-1-3-16)26-17-4-6-19(7-5-17)30-21-15-18(27-10-12-29-13-11-27)14-20-22(21)25-9-8-24-20/h7-8,13-16,18,20H,3-6,9-12H2,1-2H3,(H,28,29,30);1,6-8,13-15,17,19H,2-5,9-12H2,(H,27,28)(H,29,30,31,32);7-8,13-17,19H,2-6,9-12H2,1H3,(H,27,28,29);6-7,13-14,16-17,19H,1-5,8-12,15H2,(H,26,28);8-9,14-17,19H,1-7,10-13H2,(H,26,28)
InChIKeyVPULHWTZOOUAFI-UHFFFAOYSA-N
XLogP14.44
TPSA489.37 Ų
H-Bond Donors6
H-Bond Acceptors41
Rotatable Bonds29
Heavy Atoms164
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002238.69
LogP ≤ 514.44
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1041

Analyze N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-3-carboxamide;2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-N-[(3R)-oxolan-3-yl]pyrimidine-5-carboxamide
CID 158040088
N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-3-carboxamide;methyl 6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-3-carboxylate;N-(2-methyloxolan-3-yl)-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-N-[(3R)-oxolan-3-yl]pyrimidine-5-carboxamide
CID 158076726
2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]-N-[(3S)-oxolan-3-yl]pyrimidine-5-carboxamide
CID 138546172
6-[2-(dimethylamino)ethoxy]-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine
CID 121335601
N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-3-carboxamide;6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-3-carboxamide;2-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidine-2,5-diamine
CID 160714072
5-ethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine
CID 90454078
6-N-methyl-4-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidine-4,6-diamine;2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-4-carboxylic acid;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-propan-2-ylpyrimidin-2-amine
CID 161442099
5-bromo-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine;5-ethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridine-2-carboxamide;6-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridine-2-carboxamide;[2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidin-5-yl]-pyrrolidin-1-ylmethanone
CID 159518743
6-[2-(4-methylpiperazin-1-yl)ethoxy]-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine
CID 121335602
2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carbonitrile
CID 90443904
5,8-dimethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6,7-dihydropteridin-2-amine;5-ethenyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-(1-methyltetrazol-5-yl)-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridin-2-amine
CID 158572861
4-[2-(dimethylamino)ethoxy]-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine
CID 121335599

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine?
The IUPAC name of N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine (CID 161365846) is N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine.
What is the SMILES notation for N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine?
The canonical SMILES for N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine is CCOc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.CN(C)C(=O)c1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)C1CCC1.O=C(NC1CCC(Oc2cc(N3CCOCC3)cc3nccnc23)CC1)C1CCOC1.c1cnc2c(OC3CCC(Nc4ccc(-c5nn[nH]n5)cn4)CC3)cc(N3CCOCC3)cc2n1.
What is the InChIKey of N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine?
The InChIKey is VPULHWTZOOUAFI-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H31N7O3.C24H27N9O2.C24H30N6O3.C23H30N4O4.C23H30N4O3/c1-31(2)24(33)17-15-28-25(29-16-17)30-18-3-5-20(6-4-18)35-22-14-19(32-9-11-34-12-10-32)13-21-23(22)27-8-7-26-21;1-6-22(27-15-16(1)24-29-31-32-30-24)28-17-2-4-19(5-3-17)35-21-14-18(33-9-11-34-12-10-33)13-20-23(21)26-8-7-25-20;1-2-32-23-15-22(27-16-28-23)29-17-3-5-19(6-4-17)33-21-14-18(30-9-11-31-12-10-30)13-20-24(21)26-8-7-25-20;28-23(16-5-10-30-15-16)26-17-1-3-19(4-2-17)31-21-14-18(27-8-11-29-12-9-27)13-20-22(21)25-7-6-24-20;28-23(16-2-1-3-16)26-17-4-6-19(7-5-17)30-21-15-18(27-10-12-29-13-11-27)14-20-22(21)25-9-8-24-20/h7-8,13-16,18,20H,3-6,9-12H2,1-2H3,(H,28,29,30);1,6-8,13-15,17,19H,2-5,9-12H2,(H,27,28)(H,29,30,31,32);7-8,13-17,19H,2-6,9-12H2,1H3,(H,27,28,29);6-7,13-14,16-17,19H,1-5,8-12,15H2,(H,26,28);8-9,14-17,19H,1-7,10-13H2,(H,26,28).
What are the key properties of N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine?
N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine has a molecular weight of 2238.69 g/mol, XLogP of 14.44, 29 rotatable bonds, 6 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-5-carboxamide;6-ethoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]cyclobutanecarboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]oxolane-3-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(2H-tetrazol-5-yl)pyridin-2-amine is sourced from PubChem (CID 161365846), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).